Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Akio Yanagisawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0009-0005-6063-3111; OpenAlex author ID A5010174858. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
46
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. Comparative Study of Pathological and Imaging Findings in High-Grade Pancreatic Intraepithelial Neoplasia: A Multicenter Analysis by the Japan Study Group on E… Co-author DOI 10.1097/mpa.0000000000002710↗
  2. Concordance of human equilibrative nucleoside transporter-1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical out… Co-author DOI 10.1002/cnr2.1507↗
  3. Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy. Co-author DOI 10.1111/cas.14258↗
  4. Roles of ERCP in the Early Diagnosis of Pancreatic Cancer. Last author DOI 10.3390/diagnostics9010030↗
  5. Multicenter study of early pancreatic cancer in Japan. Co-author DOI 10.1016/j.pan.2017.11.007↗
  6. [Histopathological features of early pancreatic cancer]. Co-author DOI 10.11405/nisshoshi.115.350↗
  7. Japan Pancreatic Cancer Registry; 30th year anniversary: Japan Pancreas Society. Co-author DOI 10.1097/mpa.0b013e318258055c↗

Closest collaborators

The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keiji Hanada · 3 shared papers, 2018–2026 · strength 0.38
  2. Akinori Shimizu · 2 shared papers, 2019–2026 · strength 0.32
  3. Atsushi Kanno · 2 shared papers, 2018–2026 · strength 0.29
  4. Mamoru Takenaka · 2 shared papers, 2018–2026 · strength 0.29
  5. Takao Ohtsuka · 2 shared papers, 2018–2026 · strength 0.29
  6. Koji Yoshida · 2 shared papers, 2018–2026 · strength 0.29
  7. Toru Furukawa · 2 shared papers, 2018–2026 · strength 0.29
  8. Masayuki Kitano · 2 shared papers, 2018–2026 · strength 0.29
  9. Masao Tanaka · 2 shared papers, 2012–2026 · strength 0.26
  10. Yukiko Takayama · 1 shared paper, 2026 · strength 0.22
  11. Reiko Ashida · 1 shared paper, 2026 · strength 0.22
  12. Yasutaka Ishii · 1 shared paper, 2026 · strength 0.22
  13. Noboru Ideno · 1 shared paper, 2026 · strength 0.22
  14. Shujiro Yazumi · 1 shared paper, 2026 · strength 0.22
  15. Akira Kurita · 1 shared paper, 2026 · strength 0.22
  16. Akira Fukutomi · 2 shared papers, 2020–2022 · strength 0.20
  17. Shoji Nakamori · 2 shared papers, 2020–2022 · strength 0.20
  18. Amane Takahashi · 2 shared papers, 2020–2022 · strength 0.20
  19. Narikazu Boku · 2 shared papers, 2020–2022 · strength 0.20
  20. Naohiro Sata · 2 shared papers, 2020–2022 · strength 0.20
  21. Katsuhiko Uesaka · 2 shared papers, 2020–2022 · strength 0.20
  22. Hirochika Toyama · 2 shared papers, 2020–2022 · strength 0.20
  23. Yukiyasu Okamura · 2 shared papers, 2020–2022 · strength 0.20
  24. Soichiro Morinaga · 2 shared papers, 2020–2022 · strength 0.20
  25. Paula Ghaneh · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.